WATCH: Medicaid Program Looks to Negotiate Rising Drug Prices

Federal data reveals Medicaid spending on prescription drugs rose 25% in 2014 and an additional 14% in 2015, marking a sharp increase. At present, Medicaid is required to cover any FDA-approved drugs, including drugs with similar purposes. Massachusetts is looking to bring the price back down by picking and choosing which drugs they are required to offer. They argue the new rule will give them missing leverage that will save money for Medicaid and patients alike. Critics argue it makes accessing drugs more difficult for low-income patients who may not have options for inexpensive alternatives. The proposal is currently being reviewed by the Centers for Medicare and Medicaid Services, which has an unpredictable record on approvals.

Follow us on social media for the latest updates in B2B!


US Consumer Confidence Hits 16-Month Low on Drag From Inflation
June 29, 2022
(Bloomberg) -- US consumer confidence dropped in June to the lowest in more than a year as inflation continues to dampen Americans’ economic views. The Conference Board’s index decreased to 98.7 from a downwardly Read more
Your Relevant Solution: The Key Differentiators of Relevant Industrial
June 28, 2022
  Finding answers and delivering results is what Relevant Industrial is all about. As an industrial business in a competitive market, Relevant Industrial has learned to adapt in order to grow. Jeremy Wilcox, Read more
How Sustainability and Gamification Factor into the Future of 3PL Strategies
June 28, 2022
One of the most well-known phrases in many industries is: If you’re not innovating, you’re dying. While the saying applies to a variety of industries, today, it is cozignant of the transportation Read more